| Financial Year |
March 31 2023 |
| Monetary Funds |
22,311,619,925.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,996,110.65 |
| Accounts Receivable |
4,265,704,855.66 |
| Advances to Suppliers |
11,750,616,079.82 |
| Other Receivables |
22,088,749.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,664,650,381.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
118,163,717.05 |
| Total Current Assets |
49,151,456,719.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
510,822.76 |
| Long-term Equity Investment |
76,469,595.68 |
| Investment Properties |
189,475,502.53 |
| Fixed Assetes |
3,999,854,834.39 |
| Under-construction Projects |
1,268,179,828.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,015,810,866.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,804,947.91 |
| Deferred Income Tax Assets |
301,256,890.36 |
| Other Non-Current Assets |
391,526,039.63 |
| Sub-Total of Non-Current Assets |
7,314,438,816.72 |
| Total Assets |
56,465,895,536.07 |
| Short-Term Loans |
50,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,464,082,423.29 |
| Accounts Payable |
16,548,614,722.26 |
| Accounts Received In Advance |
87,900.00 |
| Employee Compensation Payable |
14,666,709.67 |
| Taxes Payable |
111,417,346.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
401,313,170.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,996,216.52 |
| Other Current Liabilities |
999,687,047.00 |
| Sub-Total of Current Liabilities |
41,066,447,126.46 |
| Long-term Loans |
100,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
114,721,768.45 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,752,508.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
938,131,340.08 |
| Total Liabilities |
42,004,578,466.54 |
| Paid-In Capital(Or Share Stock) |
1,960,526,295.00 |
| Capital Surplus |
5,548,694,452.51 |
| Surplus Reserve |
252,657,532.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,810,859,136.38 |
| Minority Stockholder's Interest |
971,870,195.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,489,446,874.31 |
| Owner's Equity（Stockholder's Equity） |
14,461,317,069.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
56,465,895,536.07 |
